BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9210602)

  • 1. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.
    Hüssy P; Faust H; Wagner JC; Schmid G; Mous J; Jacobsen H
    J Hepatol; 1997 Jun; 26(6):1179-86. PubMed ID: 9210602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells.
    Hüssy P; Schmid G; Mous J; Jacobsen H
    Virus Res; 1996 Nov; 45(1):45-57. PubMed ID: 8896240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
    Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
    J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins.
    Liu J; Zhu L; Zhang X; Lu M; Kong Y; Wang Y; Li G
    Biotechnol Appl Biochem; 2001 Oct; 34(2):109-19. PubMed ID: 11592917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of hepatitis C virus envelope proteins with a recombinant baculovirus expression system].
    Tang L; Xu Z; Fu L; Li G; Ren J; Yin W
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):179-82. PubMed ID: 12575178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.
    Lesniewski RR; Watanabe S; Devare SG
    Princess Takamatsu Symp; 1995; 25():129-37. PubMed ID: 8875617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
    Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
    J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia.
    Lesniewski R; Okasinski G; Carrick R; Van Sant C; Desai S; Johnson R; Scheffel J; Moore B; Mushahwar I
    J Med Virol; 1995 Apr; 45(4):415-22. PubMed ID: 7545212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal transmission of hepatitis C antigens: envelope 1, envelope 2 and non-structural 4.
    Attallah AM; Abdallah SO; El-Far M; Omran MM; Tabll AA; Ghaly MF; Ezzat SM; Elhamshary MO; El-Gohary ZM; Mohamedin AH; El-Morsi AA; Askora AA; Abdelrazek MA; El-Kafrawy HM; Keneber MH; Khalil MR; Aggag MM; Elbendary MS; El-Deeb MM; Abuzaid MS; Mansour AT; Attallah AA
    Infect Dis (Lond); 2015 Aug; 47(8):568-74. PubMed ID: 25922972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.
    Liu J; Zhu LX; Kong YY; Li GD; Wang Y
    World J Gastroenterol; 2005 Jan; 11(4):503-7. PubMed ID: 15641134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses.
    Seong YR; Choi S; Lim JS; Lee CH; Lee CK; Im DS
    Vaccine; 2001 Apr; 19(20-22):2955-64. PubMed ID: 11282207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers.
    Depraetere S; Van Kerschaever E; Van Vlierberghe H; Elewaut A; Brouwer JT; Niesters HG; Schalm SW; Maertens G; Leroux-Roels G
    J Med Virol; 2000 Feb; 60(2):126-32. PubMed ID: 10596010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.
    Petit MA; Jolivet-Reynaud C; Peronnet E; Michal Y; Trépo C
    J Biol Chem; 2003 Nov; 278(45):44385-92. PubMed ID: 12882983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of antibody against hepatitis C virus first envelope (HCV-E1) protein and its clinical application].
    Xu J; Ye L; Gao J; Zhang B; Ruan H; Wu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):392-4. PubMed ID: 12665917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
    Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
    Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.